Literature DB >> 16030175

No genetic association between EPHX1 and Crohn's disease.

W H M Peters, E M J van der Logt, R H M Te Morsche, H M J Roelofs, D J de Jong, T H J Naber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16030175      PMCID： PMC1774729          DOI： 10.1136/gut.2005.076422

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

1.  Biallelic genotype distributions in papers published in Gut between 1998 and 2003: altered conclusions after recalculating the Hardy-Weinberg equilibrium.

Authors:  B Györffy; I Kocsis; B Vásárhelyi
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

2.  Microsomal epoxide hydrolase polymorphism and susceptibility to ovarian cancer.

Authors:  S W Baxter; D Y H Choong; I G Campbell
Journal:  Cancer Lett       Date:  2002-03-08       Impact factor: 8.679

3.  A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.

Authors:  Christoph Sachse; Gillian Smith; Murray J V Wilkie; Jennifer H Barrett; Robin Waxman; Frank Sullivan; David Forman; D Timothy Bishop; C Roland Wolf
Journal:  Carcinogenesis       Date:  2002-11       Impact factor: 4.944

4.  Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer.

Authors:  J M Lancaster; H A Brownlee; D A Bell; P A Futreal; J R Marks; A Berchuck; R W Wiseman; J A Taylor
Journal:  Mol Carcinog       Date:  1996-11       Impact factor: 4.784

5.  A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas.

Authors:  V Cortessis; K Siegmund; Q Chen; N Zhou; A Diep; H Frankl; E Lee; Q S Zhu; R Haile; D Levy
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

6.  Genetic polymorphisms in biotransformation enzymes in Crohn's disease: association with microsomal epoxide hydrolase.

Authors:  D J de Jong; E M J van der Logt; A van Schaik; H M J Roelofs; W H M Peters; T H J Naber
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

7.  Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study.

Authors:  Gregory J Tranah; Edward Giovannucci; Jing Ma; Charles Fuchs; Susan E Hankinson; David J Hunter
Journal:  Carcinogenesis       Date:  2004-02-26       Impact factor: 4.944

8.  Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer.

Authors:  D J Harrison; A L Hubbard; J MacMillan; A H Wyllie; C A Smith
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

9.  Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk.

Authors:  A Gsur; T Zidek; K Schnattinger; E Feik; G Haidinger; P Hollaus; A Mohn-Staudner; C Armbruster; S Madersbacher; G Schatzl; K Trieb; C Vutuc; M Micksche
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640
  9 in total
  2 in total

1.  Association of microsomal epoxide hydrolase exon 3 Tyr113His and exon 4 His139Arg polymorphisms with gastric cancer in India.

Authors:  Ujjala Ghoshal; Sushil Kumar; Virendra Jaiswal; Shweta Tripathi; Balraj Mittal; Uday C Ghoshal
Journal:  Indian J Gastroenterol       Date:  2013-04-12

Review 2.  Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review.

Authors:  Isabelle Cleynen; Peter Jüni; Geertruida E Bekkering; Eveline Nüesch; Camila T Mendes; Stefanie Schmied; Stefan Wyder; Eliane Kellen; Peter M Villiger; Paul Rutgeerts; Séverine Vermeire; Daniel Lottaz
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.